Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPSโฅ1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
PHASE3
This study is a randomized, open-label, multicenter phase III trial designe...
Status
Recruiting
Location
The Fifth Affiliated Hospital,Sun Yat-sen University
A Prospective, Exploratory Study of Becotatug Vedotin Plus Putlimab for Neoadjuvant Therapy and Adjuvant Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
PHASE2
This is a prospective, exploratory, non-registration, multi-center clinical...
A Prospective, Single-arm, Phase II Clinical Trial of Becotatug Vedotin for Injection Combined With Pucotenlimab Injection as a First-line Treatment for Platinum-intolerant Advanced Head and Neck Squamous Cell Carcinoma
PHASE2
This study is a randomized, open-label, multi-center phase II trial evaluat...